CNS Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNSP and other ETFs, options, and stocks.About CNSP
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12.
CEOJohn M. Climaco
CEOJohn M. Climaco
Employees5
Employees5
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2017
Founded2017
Employees5
Employees5
CNSP Key Statistics
Market cap2.22M
Market cap2.22M
Price-Earnings ratio-0.04
Price-Earnings ratio-0.04
Dividend yield—
Dividend yield—
Average volume249.18K
Average volume249.18K
High today$0.2176
High today$0.2176
Low today$0.1912
Low today$0.1912
Open price$0.2176
Open price$0.2176
Volume87.25K
Volume87.25K
52 Week high$3.35
52 Week high$3.35
52 Week low$0.19
52 Week low$0.19
CNSP News
TipRanks 5d
CNS Pharmaceuticals Conducts Informational Investor MeetingsThe latest update is out from CNS Pharmaceuticals (CNSP). CNS Pharmaceuticals, Inc. is engaging with the investment community through a series of meetings, dur...